일산병원

ILSAN HOSPITAL

Medical statistics

진료통계

암의 조직학적 형태별 분포현황

  • HOME
  • 진료통계
  • 주요통계 비젼
  • 암의 조직학적 형태별 분포현황

암의 조직학적 형태별 분포현황

(단위:건,%)
Behavior of
neoplasm		 코드 조직학적 진단명 2015년 2014년 전년대비
증감율
건수 구성비 건수 구성비
Carcinoma
in situ
(정상소재암)		 M80102 Carcinoma in situ, NOS 9 0.57 18 1.06 -50.0
M80702 Squamous cell carcinoma in situ, NOS 22 1.39 12 0.70 83.3
M80772 CIN III with severe dysplasia(C53._) 7 0.44 18 1.06 -61.1
M80812 Bowen disease(C44._) 2 0.13 1 0.06 100.0
M81202 Transitional cell carcinoma in situ 6 0.38 - - -
M81302 Papillary transitional cell carcinoma, non-invasive(C67._) 25 1.58 9 0.53 177.8
M81402 Adenocarcinoma in situ, NOS 5 0.32 6 0.35 -16.7
M82012 Ductal carcinoma in situ, cribriform type(C50._) 2 0.13 1 0.06 100.0
M82102 Adenocarcinoma in situ in tubular adenoma - - 1 0.06 -100.0
M82112 Tubular adenocarcinoma in situ 2 0.13 - - -
M82302 Ductal carcinoma in situ, solid type(C50._) 2 0.13 - - -
M82612 Adenocarcinoma in situ in villous adenoma - - 1 0.06 -100.0
M82632 Adenocarcinoma in situ in tubulovillous adenoma 4 0.25 3 0.18 33.3
M85002 Ductal carcinoma in situ, NOS(C50._) 3 0.19 3 0.18 0.0
M85012 Ductal carcinoma in situ, comedo type(C50._) 5 0.32 2 0.12 150.0
M85032 Intraductal papillary neoplasm with high grade intraepithelial neoplasia 1 0.06 1 0.06 0.0
M85202 Lobular carcinoma in situ, NOS(C50._) 1 0.06 - - -
Carcinoma in situ 합계 96 6.07 76 4.46 26.3
Malignant,
primary site
(악성, 원발부위암)		 M80003 Malignant neoplasm, NOS 265 16.75 297 17.42 -10.8
M80103 Carcinoma, NOS 10 0.63 21 1.23 -52.4
M80133 Large cell neuroendocrine carcinoma - - 1 0.06 -100.0
M80203 Carcinoma, undifferentiated, NOS - - 1 0.06 -100.0
M80213 Carcinoma, anaplastic, NOS 1 0.06 - - -
M80323 Spindle cell carcinoma, NOS - - 1 0.06 -100.0
M80333 Pseudosarcomatous carcinoma 4 0.25 3 0.18 33.3
M80413 Small cell carcinoma, NOS 27 1.71 27 1.58 0.0
M80463 Non-small cell carcinoma(C34._) 16 1.01 44 2.58 -63.6
M80503 Papillary carcinoma, NOS - - 3 0.18 -100.0
M80523 Papillary squamous cell carcinoma 1 0.06 2 0.12 -50.0
M80703 Squamous cell carcinoma, NOS 101 6.38 97 5.69 4.1
M80713 Squamous cell carcinoma, keratinizing, NOS 6 0.38 1 0.06 500.0
M80723 Squamous cell carcinnoma, large cell, nonkeratinizing, NOS 5 0.32 5 0.29 0.0
M80903 Basal cell carcinoma, NOS(C44._) 12 0.76 7 0.41 71.4
M81203 Transitional cell carcinoma, NOS 30 1.90 31 1.82 -3.2
M81303 Papillary transitional cell carcinoma (C67._) 13 0.82 35 2.05 -62.9
M81403 Adenocarcinoma, NOS 339 21.43 364 21.35 -6.9
M81473 Basal cell adenocarcinoma 1 0.06 - - -
M81603 Cholangiocarcinoma(C22.1, C24.0) 31 1.96 38 2.23 -18.4
M81623 Klatskin tumor(C22.1, C24.0) 3 0.19 7 0.41 -57.1
M81703 Hepatocellular carcinoma, NOS(C22.0) 101 6.38 86 5.04 17.4
M82003 Adenoid cystic carcinoma - - 3 0.18 -100.0
M82103 Adenocarcinoma in tubular adenoma 7 0.44 4 0.23 75.0
M82113 Tubular adenocarcinoma 77 4.87 68 3.99 13.2
M82303 Solid carcinoma, NOS 2 0.13 2 0.12 0.0
M82403 Neuroendocrine tumor, grade 1 3 0.19 5 0.29 -40.0
M82463 Neuroendocrine carcinoma, NOS 3 0.19 2 0.12 50.0
M82473 Merkel cell carcinoma(C44._) - - 1 0.06 -100.0
M82493 Neuroendocrine tumor, grade 2 1 0.06 1 0.06 0.0
M82503 Bronchiolo-alveolar adenocarcinoma, NOS(C34._) - - 3 0.18 -100.0
M82603 Papillary adenocarcinoma, NOS 114 7.21 147 8.62 -22.4
M82633 Adenocarcinoma in tubulovillous adenoma 6 0.38 2 0.12 200.0
M82653 Micropapillary carcinoma, NOS (C18._, C19.9, C20.9) 1 0.06 - - -
M82903 Hurthle cell carcinoma(C73.9) - - 1 0.06 -100.0
M83103 Clear cell adenocarcinoma, NOS 3 0.19 5 0.29 -40.0
M83123 Renal cell carcinoma, NOS(C64.9) 13 0.82 21 1.23 -38.1
M83173 Renal cell carcinoma, chromophobe type(C64.9) 2 0.13 - - -
M83233 Mixed cell adenocarcinoma 1 0.06 - - -
M83303 Follicular adenocarcinoma, NOS(C73.9) 2 0.13 - - -
M83353 Follicular carcinoma, minimally, invasive(C73.9) - - 2 0.12 -100.0
M83403 Papillary carcinoma, follicular variant(C73.9) - - 1 0.06 -100.0
M83703 Adrenal cortical carcinoma(C74.0) 1 0.06 1 0.06 0.0
M83803 Endometrioid carcinoma, NOS 7 0.44 13 0.76 -46.2
M83843 Adenocarcinoma, endocervical type 2 0.13 1 0.06 100.0
M84303 Mucoepidermoid carcinoma 2 0.13 - - -
M84413 Serous adenocarcinoma, NOS 3 0.19 4 0.23 -25.0
M84533 Intraductal papillary-mucinous carcinoma, invasive(C25._) 3 0.19 - - -
M84603 Papillary serous cystadenocarcinoma(C56.9) 3 0.19 - - -
M84613 Serous surface papillary carcinoma(C56.9) 1 0.06 1 0.06 0.0
M84703 Mucinous cystadenocarcinoma, NOS(C56.9) 1 0.06 - - -
M84803 Mucinous adenocarcinoma 10 0.63 11 0.65 -9.1
M84903 Signet ring cell carcinoma 30 1.90 26 1.52 15.4
M85003 Infiltrating duct carcinoma, NOS(C50._) 72 4.55 64 3.75 12.5
M85103 Medullary carcinoma, NOS 1 0.06 - - -
M85203 Lobular carcinoma, NOS(C50._) 7 0.44 - - -
M85413 Paget disease and infiltrating duct carcinoma of breast(C50._) 1 0.06 - - -
M85503 Acinar cell carcinoma 32 2.02 25 1.47 28.0
M85603 Adenosquamous carcinoma - - 3 0.18 -100.0
M85753 Metaplastic carcinoma, NOS - - 1 0.06 -100.0
M85813 Thymoma, type A, malignant(C37.9) 1 0.06 1 0.06 0.0
M85843 Thymoma, type B2, malignant(C37.9) 1 0.06 - - -
M87203 Malignant melanoma, NOS (except jubenile melanoma M-8770/0) 5 0.32 6 0.35 -16.7
M87213 Nodular melanoma(C44._) - - 1 0.06 -100.0
M88003 Sarcoma, NOS - - 1 0.06 -100.0
M88023 Pleomorphic cell sarcoma 1 0.06 3 0.18 -66.7
M88053 Undifferentiated sarcoma - - 1 0.06 -100.0
M88113 Fibromyxosarcoma - - 1 0.06 -100.0
M88153 Solitary fibrous tumor, malignant 1 0.06 - - -
M88303 Malignant fibrous histiocytoma - - 2 0.12 -100.0
M88323 Dermatofibrosarcoma, NOS(C44._) - - 1 0.06 -100.0
M88503 Liposarcoma, NOS 1 0.06 - - -
M88523 Myxoid liposarcoma 2 0.13 1 0.06 100.0
M88903 Leiomyosarcoma, NOS - - 2 0.12 -100.0
M89003 Rhabdomyosarcoma, NOS - - 1 0.06 -100.0
M89313 Endometrial stromal sarcoma, low grade(C54.1) - - 1 0.06 -100.0
M89333 Adenosarcoma 1 0.06 - - -
M89363 Gastrointestinal stromal sarcoma 6 0.38 7 0.41 -14.3
M89803 Carcinosarcoma, NOS 4 0.25 1 0.06 300.0
M89823 Malignant myoepithelioma - - 1 0.06 -100.0
M90203 Phyllodes tumor, malignant(C50._) - - 1 0.06 -100.0
M90503 Mesothelioma, malignant 3 0.19 2 0.12 50.0
M90613 Seminoma, NOS(C62._) - - 1 0.06 -100.0
M90643 Germinoma 1 0.06 - - -
M90803 Teratoma, malignant, NOS - - 3 0.18 -100.0
M90853 Mixed germ cell tumor 2 0.13 - - -
M91203 Hemangiosarcoma 1 0.06 2 0.12 -50.0
M91803 Osteosarcoma, NOS(C40._, C41._) 2 0.13 - - -
M92203 Chondrosarcoma, NOS(C40._, C41_) 1 0.06 - - -
M93823 Mixed glioma(C71._) - - 3 0.18 -100.0
M94003 Astrocytoma, NOS(C71._) 1 0.06 1 0.06 0.0
M94013 Astrocytoma, anaplastic(C71._) 3 0.19 1 0.06 200.0
M94103 Protoplasmic astrocytoma(C71._) - - 1 0.06 -100.0
M94203 Fibrillary astrocytoma(C71._) 1 0.06 - - -
M94403 Glioblastoma, NOS(C71._) 6 0.38 6 0.35 0.0
M94513 Oligodendroglioma, anaplastic(C71._) - - 1 0.06 -100.0
M95903 Malignant lymphoma, NOS 1 0.06 1 0.06 0.0
M96523 Hodgkin lymphoma, mixed cellularity, NOS 1 0.06 - - -
M96533 Hodgkin lymphoma, lymphocyte depletion, NOS 2 0.13 1 0.06 100.0
M96733 Mantle cell lymphoma
(includes all variant: blastic, pleomorphic, small cell)		 3 0.19 - - -
M96803 Malignant lymphoma, large B-cell, diffuse, NOS 17 1.07 19 1.11 -10.5
M96873 Burkitt lymphoma, NOS - - 1 0.06 -100.0
M96883 T-cell/histiocyte rich large B-cell lymphoma 1 0.06 - - -
M96903 Follicular lymphoma, NOS 1 0.06 1 0.06 0.0
M96983 Folloicular lymphoma, grade 3 1 0.06 1 0.06 0.0
M96993 Marginal zone B-cell lymphoma, NOS 5 0.32 4 0.23 25.0
M97023 Mature T-cell lymphoma, NOS 1 0.06 4 0.23 -75.0
M97143 Anaplastic large cell lymphoma, T cell and Null cell type - - 1 0.06 -100.0
M97193 NK/T-cell lymphoma, nasal and nasal-type - - 3 0.18 -100.0
M97313 Plasmacytoma, NOS 2 0.13 - - -
M97323 Multiple myeloma(C42.1) 5 0.32 4 0.23 25.0
M97513 Langerhans cell histiocytosis, NOS 2 0.13 1 0.06 100.0
M97553 Histiocytic sarcoma 1 0.06 - - -
M97613 Waldenstrom macroglobulinemia(C42.0) 1 0.06 - - -
M98003 Leukemia, NOS 3 0.19 - - -
M98013 Acute leukemia, NOS 4 0.25 1 0.06 300.0
M98603 Myeloid leukemia, NOS 2 0.13 - - -
M98613 Acute myeloid leukemia, NOS 1 0.06 - - -
M98633 Chronic myeloid leukemia, NOS 2 0.13 1 0.06 100.0
M98723 Acute myeloblastic leukemia 2 0.13 5 0.29 -60.0
M98743 Acute myeloid leukemia with maturation - - 1 0.06 -100.0
M99303 Myeloid sarcoma 2 0.13 - - -
M99313 Acute panmyelosis with myelofibrosis(C42.1) 1 0.06 - - -
M99453 Chronic myelomonocytic leukemia, NOS 1 0.06 - - -
M99613 Primary myelofibrosis 1 0.06 - - -
M99623 Essential thrombocythemia - - 1 0.06 -100.0
M99803 Refractory anemia - - 1 0.06 -100.0
M99833 Refractory anemia with excess of blasts - - 1 0.06 -100.0
M99893 Myelodysplastic syndrome, NOS 2 0.13 5 0.29 -60.0
Malignant, primary site 합계 1,486 93.93 1,599 93.78 -7.1
총합계 1,582 100.00 1,705 100.00 -7.2
 

  • (우)10444 경기도 고양시 일산동구 일산로 100(백석1동 1232번지) 대표전화 : 031-900-0114 팩스 : 031-900-0049
  • Copyright ＠ NATIONAL HEAL TH INSURANCE SERVICE IL SANHOSPITAL. ALL RIGHTS RESERVED.